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ABSTRACT 
 
This project was designed to validate antimicrobial applications on intact beef 
subprimals, frozen beef, and moisture-enhanced beef for the reduction of Shiga toxin-
producing Escherichia coli (STEC). In-plant validation trials were conducted to 
determine efficacy of interventions on Biotype I STEC surrogate microorganisms 
(ATCC: BAA-1427, BAA-1428, BAA-1429, BAA-1430, and BAA-1431). Two culture 
preparation and inoculation methods were evaluated. There was no difference (P > 0.05) 
between reductions of surrogate microorganisms on beef surfaces for inoculum 
preparation methods or for inoculation temperatures. In-plant evaluation of antimicrobial 
interventions for various beef cuts inoculated with surrogate E. coli and subsequently 
treated with solutions of lactic acid (3.5%), Citrilow™ (pH = 1.05), Beefxide® (2.0%), 
or peroxyacetic acid blends (PAA, 150 ppm-Inspexx™150 and 190 ppm-Inspexx™ 200) 
resulted in reductions ranging from 0.1 to 0.8 log10 CFU. Following in-plant 
experiments, a trial evaluating the efficacy of antimicrobial solutions prepared using 
water from different sources was conducted, and source did not affect (P > 0.05) 
reductions of E. coli. Additionally, warm (55˚C) lactic acid applied to frozen, inoculated 
beef trimmings at concentrations of 2.5% and 5.0% achieved reductions of 0.5 and 0.7 
log10 CFU/g, respectively. Differences in reductions of E. coli achieved by lactic acid 
(2.5 and 5.0% treatment groups) applied to fresh and frozen beef surfaces were 
evaluated, and reductions achieved on frozen cuts treated with 5.0% lactic acid were 
greater (P < 0.0001) than reductions from either of the fresh treatment groups. Applying 
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lactic acid to frozen beef resulted in up to a 0.6 log10 CFU/cm2 greater reduction than 
when applied to fresh beef. Bottom sirloin tri-tips were marinated using cetylpyridinium 
chloride (CPC; 0.02%, 0.05%, or 0.10%; added as Cecure®) or sodium metasilicate 
(SMS, 0.2%, added as AvGard® XP) as antimicrobial treatments. There were no 
differences (P > 0.05) among treatments for reduction of surface or internalized 
surrogate E. coli. These data suggest that additional research should be conducted to 
determine the most suitable application of these ingredients for moisture-enhanced beef 
products. Overall, these results can be used by processors to fulfill the regulatory 
requirements for validating their food safety/HACCP programs. 
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CHAPTER I  
INTRODUCTION 
 
Pathogenic microorganisms in foods are a threat to human health and have the 
potential to cause fatalities and severe illnesses.  Foodborne pathogens cause 
approximately 9.4 million illnesses, 56,000 hospitalizations, and 1,400 deaths in the 
United States (U.S.) annually (58). Consumption of beef products contaminated with 
Shiga-toxigenic Escherichia coli (STEC) have been associated with illnesses ranging 
from mild diarrhea to severe hemolytic uremic syndrome (101). Ruminant animals are 
one of the primary reservoirs of STECs, and research has shown these pathogens can 
spread from the feces on the hide onto the carcass during the beef harvest process, 
resulting in contamination of some parts of the carcass (8-10, 13, 38). 
In 1992 and 1993, a foodborne illness outbreak resulting in several deaths and 
numerous hospitalizations was linked to the consumption of undercooked ground beef 
(22). The associated beef products were later found to be contaminated with Escherichia 
coli (E. coli) O157:H7. In response, the Food Safety and Inspection Service (FSIS) of 
the U.S. Department of Agriculture (USDA) declared E. coli O157:H7 to be an 
adulterant in raw, ground beef products (117). Multiple foodborne illness outbreaks 
involving 6 non-O157 STECs (O26, O45, O103, O111, O121, O145) led the FSIS to 
later classify these strains as adulterants in raw, ground and raw, non-intact beef 
products (14, 41, 113). STECs pose a threat to consumers’ health and can negatively 
impact the economy of the beef industry.  
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Meat processing establishments have designed and implemented control 
measures to assist in compliance with the mandated Hazard Analysis and Critical 
Control Points (HACCP) regulation by FSIS (111). Antimicrobial interventions are used 
by the beef industry as a part of these HACCP/food safety systems to address specific 
pathogens of concern. Much of the early research for reducing pathogen contamination 
focused on the application of antimicrobial interventions to the carcasses during harvest 
and upon entering fabrication (59). Several studies have reported on the efficacy of 
antimicrobial treatments applied to warm and chilled beef carcasses or trimmings to 
reduce the level of enteric pathogens (17-21, 32, 33, 39, 40, 51, 65, 74, 123). The FSIS 
(113) declared the public health risks associated with raw beef products contaminated 
with E. coli O157:H7 and non-O157 STECs are not limited to ground beef, but also 
include non-intact beef products. Thus, further processors must have sufficient scientific 
data to support the use of antimicrobial interventions in their processes. Although the 
efficacy of many commonly applied antimicrobial interventions has been demonstrated 
in a laboratory setting, the results obtained in-plant vary, and unfortunately are 
sometimes less effective than in a laboratory trial. Therefore, it is important that in-plant 
validation studies be conducted to demonstrate efficacy of their food safety systems and 
antimicrobial interventions in full-scale applications.  
Further processing is a complex system because there are multiple production 
processes, and varying procedures and equipment are used at different establishments. 
The application methods of antimicrobials in some operations differ from those in the 
published research making it difficult for processors to adequately support their 
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decisions, which creates issues during Food Safety Assessments (FSAs) and audits. 
Furthermore, a large percentage of further processing is conducted by small and very 
small establishments that do not have the technical staff and/or resources to conduct 
validation studies for the processing aids and interventions applied in their operations.  
Therefore, the purpose of this study was to evaluate the efficacy of in-plant 
applications of commonly applied antimicrobial interventions during the production of 
raw intact, non-intact, and ground beef products and to explore the use of novel 
application methods and/or less frequently used antimicrobial interventions during the 
production of raw intact, non-intact, and ground beef products.  
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CHAPTER II 
REVIEW OF LITERATURE 
 
2.1 Foodborne Pathogens 
 Illnesses caused by foodborne pathogens have been documented for nearly 200 
years. A pathogen is a microorganism, when contracted by humans, which can cause 
disease or illness. Some of the most common foodborne pathogens include 
Campylobacter, Listeria, Salmonella, Shiga toxin–producing Escherichia coli, Shigella, 
Vibrio, and Yersinia. The first case of illnesses linked to a specific organism was in 1888 
when 57 people were sickened from meat contaminated with Salmonella Enteritidis (67). 
Escherichia coli (E. coli) has been identified as a foodborne pathogen since a shipment 
of imported cheese was linked to almost 400 illnesses in 1971 (62). In 1982 the first 
documented cases of illness caused by E. coli in meat products was linked to hamburger 
meat from a fast food restaurant in Oregon and Michigan (100). Perhaps the most widely 
publicized case of E. coli in meat was in 1992 and 1993 when over 700 illnesses were 
associated with the consumption of undercooked hamburgers from a fast-food restaurant 
(22). The strain of E. coli linked to these illnesses was identified as E. coli O157:H7, an 
enterohemmorhagic E. coli (EHEC) that can cause illnesses ranging from mild diarrhea 
to severe hemolytic uremic syndrome (34, 62). E. coli O157:H7 as well as several other 
serotypes (O26, O45, O103, O111, O121, O145, and others) are known as Shiga-
toxigenic E. coli (STEC). While the occurrence of foodborne STEC illnesses is more 
commonly attributed to meat and poultry products, several recent outbreaks have been 
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linked to fresh produce, sprouts, and other foods. However, the reduction of STEC 
remains one of the primary objectives of the food safety systems in beef harvest and 
processing establishments. 
2.2 Escherichia coli 
In 1885, E. coli was first isolated by the bacteriologist Theodor Escherich from 
infant stools while studying the intestinal bacteria and their relation to pathologic 
conditions in infants. Escherichia coli is a predominant part of intestinal microbiome for 
various species, which includes cattle, sheep, horses, wild game, dogs, cats, and humans 
(1, 62). Ruminant animals tend to be the most common reservoirs for E. coli (9, 43). The 
genus Escherichia is part of the family Enterobacteriaceae and includes 6 species: E. 
hermanii, E. fergusonii, E. vulneris, E. blattae, E. albertii, and E. coli (1). Additional 
members of the Enterobacteriaceae family include other enteric pathogens such as 
Salmonella spp., Shigella spp., and Yersinia spp., all of which can be human 
pathogens. Although most strains of E. coli have been described as harmless 
microorganisms, some serotypes can be an opportunistic pathogen in 
immunocompromised patients (1). Many pathogenic strains E. coli can be responsible 
for urinary tract infections, while some pathogenic strains are attributed to foodborne 
illness. 
Escherichia coli is a non-spore forming, gram-negative, facultative anaerobic, 
mesophilic bacteria. The cell has a rod shape and flagella, if present, are in a 
peritrichious arrangement. Most strains ferment glucose with production of acid and gas, 
and lactose is fermented with production of both acid and gas by most strains. E. coli 
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grows at temperatures ranging from 7-10ºC and up to 50ºC. The optimum temperature 
for growth is 37ºC. These bacteria do not have a marked heat resistance, with a D-value 
at 60ºC of 0.1 min, but can survive refrigeration and freezing temperatures for prolonged 
periods. The optimal pH for growth is 7.0 but has been shown to grow at a pH as low as 
4.4 if all other conditions are in optimal ranges. Under optimum conditions, the 
minimum aw for growth is 0.95 (1, 62). The time from exposure to onset of symptoms 
ranges from 1 to 14 days (25). 
Kauffmann established the basis for the serological studies of the 
lipopolysaccharide somatic-O antigen, capsular-K antigen and flagellar-H antigenic 
reaction of the coli group (71). Kauffmann described the relationship of the K antigen 
with the strain and, the O antigen classification group and its necrotizing hemolytic and 
toxicity virulence factors. Serogroups are defined by O antigens and then subdivided into 
serotypes based on H antigens. Strains of each category of pathogenic E. coli tend to fall 
within certain O:H serotypes. This method plays an important role in the detection of 
pathogens and for epidemiological studies (1, 71, 84). In 1988, 171 O serogroups and 56 
H types were recognized (66, 77, 89). 
2.3 Pathogenic E. coli 
Some E. coli help to maintain gastrointestinal functions and are not harmful to 
humans (26). These are known as generic E. coli, or biotype-I E. coli, while other strains 
are major causes of different syndromes of diarrheal disease and are called pathogenic E. 
coli (69, 77). Some of these pathogenic E. coli share some virulence characteristics such 
as plasmids encoding for critical virulence factors, the particular interaction with the 
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intestinal mucosa, and the production of enterotoxins or cytotoxins. (77).  
There are 6 recognized virulence groups for E. coli: enteropathogenic (EPEC), 
enterotoxigenic (ETEC), enteroinvasive (EIEC), enteroaggregative (EAggEC), diffuse-
adherent (DAEC) and enterohemorrhagic (EHEC) (66, 69, 77, 89). The EPEC group is 
recognized as the main cause of infantile diarrhea. These strains do not develop the heat-
labile and heat-stable enterotoxins found in ETEC. EPEC do not exhibit the invasiveness 
of EIEC. They do produce a toxin almost identical to Toxin 1 from Shigella dysenteriae 
which causes diarrhea by destruction of microvilli without further invasion (77). 
Common symptoms of EPEC infection include fever, malaise, vomiting, and diarrhea 
with an elevated amount of mucus but without blood (77). EIEC infection frequently 
causes watery to bloody diarrhea (hemorrhagic colitis) and vomiting. The EHEC group 
is very similar to EPEC due to the fact they possess common genes, the type of 
attachment, and epithelial effacement lesions. EHEC are a subset of a group called vero 
cytotoxin-producing E. coli (VTEC). These strains produce toxins that are toxic to vero 
(African green monkey kidney) tissue cultured cells, giving them the name vero 
cytotoxins (35, 36, 75). Some literature has described the expression of toxins similar to 
Shigella dysenteriae (Shiga toxin). These toxins were different from any previously 
described E. coli toxins and are named Stx1 and Stx2 (62). Common nomenclature of 
these bacteria can be either VTEC or STEC (Shiga toxin-producing E. coli). Virulence 
genes of the pathogenic island on the chromosome of STEC include the eae gene that 
encodes the intimin protein which is essential for attachment/effacement (A/E), observed 
through the attachment of the bacteria to the epithelial cells in the lining of the intestines. 
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Another virulence gene that STEC can carry is the EHEC-hemolysin (hlyA) gene. The 
presence of these 2 virulence factors in combination with the production of the Shiga 
toxin, potentially results in these highly virulent strains of STEC (11, 64). The host 
receptor for these toxins is globotriasylceramide (Gb3). Human renal tissue contains 
large amounts of Gb3 and thus it is highly sensitive to the Stx toxins, which can lead to 
hemolytic uremic syndrome (HUS) symptoms such as hemolytic anemia, 
thrombocytopenia, and acute renal failure. Often, death of renal cells occurs due to 
ribosome destruction, which inhibits protein synthesis (62, 92). In the elderly, 
Thrombotic thrombocytopenic purpura (TTP) is seen when a combination of HUS, fever 
and neurologic dysfunctions are present. Left untreated, TTP has an approximate 
mortality rate of 95%; though, survival rates of 80-90% can be seen with early diagnosis 
(68). Other STEC strains have been related with hemorrhagic colitis and HUS; however, 
E. coli O157:H7, the most widely known member of the group, is currently recognized 
as the most common cause of STEC-associated human illness (34).  
2.4 Sources and Epidemiology 
A STEC infection can have different clinical manifestations. These differences 
are related to the patient, the dose of the pathogen, and the infecting strain. Some strains, 
such as E. coli O157:H7 could cause infection with as few as 100 cells (84). The highest 
risk groups for infection are children under 5 years, elderly, and immunocompromised 
individuals (52). STEC infections are transmitted via 3 primary routes: directly from 
animals (farm animals, domestic pets, deer, dogs, wild birds), by person-to-person 
contact such as day care centers and nursing homes, and from contaminated foods and 
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water (62). Ground beef has been associated with several outbreaks in humans (92). 
Although beef products are the most common cause of illnesses related to STEC, many 
outbreaks also have been linked to a wide variety of food items. Raw milk also has been 
related to outbreaks and HUS syndrome in humans and STEC has been isolated from 
healthy dairy cattle (119). Hazelnuts, fresh produce, cheese, juice, yogurt, dried salami, 
raw milk, mayonnaise, and raw cookie dough are examples of food matrixes that have 
been involved in STEC related illnesses (24, 42, 63, 97). Because more foodborne 
outbreaks of STEC syndromes have been linked to beef than any other single food 
source, cattle have typically been considered the primary reservoir for STEC in United 
States (22). STEC also has been found in other ruminants in several countries (34). 
STEC can be found in cattle gastrointestinal tract and excreted in feces and been isolated 
from fecal samples collected from healthy calves or cattle in the U.S., Canada, United 
Kingdom, Germany, and Spain (62).  
Current research has established that STEC is transferred via fecal contamination 
from the hide, hooves, and other parts of the animal onto the carcass during harvest (4-6, 
8-10, 12, 13, 38, 91). Bosilevac et al. (12) sampled 1,995 hides and 1,995 carcasses in 7 
U.S. harvest facilities finding prevalence of enumerable levels of E. coli O157:H7 and 
Salmonella of 12 and 36% in hides of stunned animals, and of 2 and 8% for carcasses on 
the pre-evisceration process. Elder et al. (38) investigated cattle at 4 different 
Midwestern U.S. harvest facilities and found 72% of lots with at least 1 positive fecal 
sample for E. coli O157:H7 and 38% of the same lots with at least 1 positive hide 
sample for this pathogen. However Arthur et al. (6) found even when 75% of the hides 
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sampled were positive for E. coli O157:H7, none of the post-chill carcasses tested 
positive for the pathogen. These results suggest levels of STEC on the carcass can be 
controlled using effective food safety interventions at different locations in the harvest 
process. Major components that effect carcass contamination are: amount of hide 
contamination, use of proper sanitary dressing procedures, and the efficacy of the food 
safety interventions during processing (120).  
2.5 Regulatory Food Safety  
In 2015, the Centers for Disease Control and Prevention (CDC) data for culture-
confirmed bacterial infections reported there were 1,259 cases, 306 hospitalizations, and 
4 deaths attributed to foodborne STEC (58). However, due to underdiagnoses and 
underreporting, the CDC’s estimates for 2016 expect that foodborne STEC is 
responsible for over 175,000 illnesses, 2,400 hospitalizations, and 20 deaths each year 
(102). Escherichia coli O157:H7 is estimated to cause 63,153 illnesses followed by 
112,752 cases of non-O157 STEC strains (O26, O45, O103, O111, O121, O145) every 
year in the U.S. (102). However, because the detection and isolation of these strains is 
costly and time consuming, it is possible that the number of foodborne illnesses caused 
by non-O157 STEC may truly be higher (14, 60). The annual healthcare expenses related 
to STEC foodborne illnesses are estimated to be $478 million (Economic Research 
Service - USDA, 2009).  
Regulatory measures have been taken by FSIS to protect public health against E. 
coli O157:H7 since 1982, when it was first recognized as a human pathogen (100). In 
August 1994, FSIS declared E. coli O157:H7 an adulterant in raw, ground beef and 
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products intended for production of raw, ground beef (117). On July 25, 1996, FSIS 
issued the final rule, named Pathogen Reduction; Hazard Analysis and Critical Control 
Point (HACCP) Systems (111). This rule addresses foodborne illness associated with 
meat and poultry products by focusing more attention on the prevention and reduction of 
microbial pathogens on raw products that can cause illness.  
The HACCP rule require meat and poultry establishments under Federal 
inspection take responsibility for, among other things, reducing the contamination of 
meat and poultry products with disease-causing (pathogenic) microorganisms by 
implementing a system, known as HACCP, of preventive controls designed to improve 
the safety of their products. The HACCP requirements that establishments must meet are 
set out in 9 CFR Part 417. These requirements are based on the 7 HACCP principles 
recommended by the National Advisory Committee on Microbiological Criteria for 
Food (NACMCF) in 1992 (88). One of the principles identified by the NACMCF was 
“Verification” describing that HACCP systems should be systematically verified. In the 
NACMCF explanation of the verification principle, which FSIS follows, an 
establishment is responsible for the following 3 processes encompassing the verification 
principle: Validation, Verification, and Reassessment (115). FSIS stated in the HACCP 
Final Rule that validation data for any HACCP system must include practical data or 
information reflecting an establishment’s actual experience in implementing the HACCP 
system.  
In January, 1999, FSIS also declared that any non-intact (injected, mechanically 
tenderized, blade- or needle-tenderized, etc.) beef containing E. coli O157:H7 would be 
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considered adulterated (112). FSIS announced that 6 additional serotypes of E. coli 
(O26, O45, O103, O111, O121, and O145) are considered adulterants in raw, ground 
beef and raw non-intact beef in September 2011 and May 2012, respectively (113). This 
announcement meant that beef processing establishments should re-assess their HACCP 
plans to identify methods to control, as well as perform additional verification 
procedures for the presence of STEC. This followed a petition filed by food safety 
advocate groups who argued that all pathogenic STEC posed threats equal to E. coli 
O157:H7. In May 2015, FSIS began requiring the labeling of raw or partially cooked 
needle- or blade- tenderized beef products (114). Including beef products injected with 
marinade or solution, these labels should bear a descriptive designation that clearly 
indicates the product has been mechanically tenderized. As mentioned in the final rule, 
the affected products must include the descriptive designation ‘mechanically tenderized,’ 
‘blade tenderized,’ or ‘needle tenderized’ and an accurate description of the beef 
component. Even though vacuum-tumbled or enzyme-formed beef products are 
processed in a way that they can introduce pathogens below the product surface, FSIS 
has concluded there are not sufficient data to understand whether the risk that pathogens 
may be introduced into product as a result of vacuum tumbling or enzyme formed beef 
product is similar to that associated with needle- and blade-tenderized beef (114).  
Recalled product associated with a positive test for STEC can have a meaningful 
impact on the profitability of beef processors. From 2000 to 2012, a total of 172 recalls 
by FSIS-regulated establishments took place due to STEC adulteration, and were 
associated mostly with beef products (103). An estimated 84,000,000 lb of beef, pork, 
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and bison products were recalled during this same period (103). As another example, the 
median ground beef recall involved an estimated 98,000 lb of product with a retail value 
of nearly $235,000 (107). Furthermore, a food safety recall that receives public attention 
is believed to have an effect on the short-term demand of beef, potentially resulting in as 
much as $97,000,000 in lost revenue to the beef industry over a 2-week period after the 
recall (107). These examples help to further demonstrate the importance of the 
implementation of validated food safety interventions in beef processing. 
Antimicrobial interventions are used by the beef industry as a part of these 
HACCP/food safety systems to address specific pathogens of concern. Early research on 
the reduction of pathogen contamination was focused on the antimicrobial intervention 
application to carcasses during harvest and upon entering fabrication (59). Several 
studies have reported on the efficacy of antimicrobial treatments applied to warm and 
chilled beef carcasses or trimmings to reduce the level of enteric pathogens (18-21, 32, 
33, 39, 47, 53, 65, 123). Although the efficacy of many commonly applied antimicrobial 
interventions has been demonstrated in a laboratory setting, the results obtained in-plant 
vary, and unfortunately are sometimes less desirable than expected. Further processing is 
a complex system because there are multiple production processes used, and varying 
procedures and equipment are used at different establishments. Further processors must 
have sufficient scientific data to support the use of antimicrobial interventions in their 
processes. The application methods in some operations differ from those in the published 
research making it difficult for them to support their decisions, which creates issues 
during Food Safety Assessments (FSAs) and audits. Furthermore, a large percentage of 
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further processing is conducted by small and very small establishments that do not have 
the technical staff and/or resources to conduct validation studies for the processing aids 
and interventions applied in their operations. Therefore, it is important that in-plant 
validation studies are conducted to demonstrate efficacy of food safety systems and 
antimicrobial interventions in full-scale applications.  
2.6 Non-intact and Raw, Ground Beef 
 As referenced in the above section, FSIS defines non-intact beef as injected, 
mechanically tenderized, and/or blade- or needle-tenderized. Studies (56, 78, 99) have 
reported that piercing of the surface using needles or blades may allow microorganisms 
an opportunity to become internalized. Internalization of surface pathogens is the 
primary concern for non-intact beef products. Furthermore, grinding of beef provides an 
opportunity for any microorganisms on the surface of a cut to become dispersed 
throughout a much larger area within a ground beef lot. For these reasons, the current 
antimicrobial interventions in use by further processors are aimed at reducing surface 
contamination of carcasses and subprimals before mechanical tenderization takes place.  
2.7 Surrogate E. coli 
 Surrogates are microorganisms that can display similar or identical properties of 
one or more pathogens. Surrogates can be useful in research to help validate pathogen 
intervention strategies in a laboratory or production setting without exposing the 
equipment, facilities, or consumers to the pathogens. Therefore, effective surrogate 
microorganisms should be non-pathogenic, have well defined characteristics, be easily 
enumerated, have similar tolerances/susceptibilities to the target pathogen, and be easily 
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differentiated from other microorganisms that may be present (62). Marshall et al. (81) 
compared 5 indicators with 5 isolates of E. coli O157:H7. The isolates were subjected to 
7 different antimicrobial treatments and the results showed these indicators in a 
combined cocktail could serve to evaluate and validate antimicrobial interventions for 
beef carcasses. Niebuhr et al. (90) used these E. coli biotype I strains to compare their 
responses to that of a mixed culture of Salmonella. Results from this study showed 4 of 
the 5 surrogates exhibited a higher survival rate when exposed to the same antimicrobial 
interventions, indicating the isolates could also be used as surrogates for Salmonella. 
Cabrera-Diaz et al. (16) compared the growth, acid and thermal resistance, and 
attachment properties of the non-pathogenic E. coli strains to those of E. coli O157:H7 
and Salmonella strains. The results of the trial found thermal and acid resistance of the 
nonpathogenic E. coli strains were not different or slightly higher than that of the E. coli 
O157:H7 and Salmonella strains, which would allow them to be a suitable surrogate 
organism for validating hot water and lactic acid interventions on beef carcasses. 
Keeling et al. (72) conducted trials to determine the effect of freezing, refrigerating, 
fermentation, and thermal inactivation on the E. coli biotype I isolates compared to E. 
coli O157:H7. Their research showed 3 of the isolates, BAA-1427, BAA-1429, and 
BAA-1430, showed no difference for refrigeration conditions and had slightly better 
survival in the frozen, fermentation, and thermal inactivation studies than E. coli 
O157:H7, which could allow for a margin of safety.  
 
 
  16 
2.8 Antimicrobial Interventions for Controlling STEC in Beef  
Due to foodborne pathogen outbreaks associated with meat products and the need 
to continuously improve safety strategies against foodborne pathogens, research has 
been focused on controlling pathogens at an initial fresh beef carcass level. A vast 
amount of research has been done on methods to decontaminate freshly slaughtered beef 
carcasses which are contaminated by feces from intestines, hide, or hooves (53, 59, 86, 
104, 105, 108). Various techniques used to control STEC contamination during beef 
processing may include: use of bacteriophage treatment, live animal cleaning, hide 
decontamination after stunning, trimming and steam vacuuming of defined carcass areas, 
whole-carcass steam, hot water, and/or chemical intervention sprays, and proper carcass 
chilling (18-21, 28, 30, 32, 49, 51, 53, 80). In the beef harvest establishment, these types 
of interventions are used in a ‘multiple-hurdle’ approach applied in combination 
throughout the process as an attempt to control microorganisms and increase the safety 
of the end products (59, 86, 87, 120). These practices are ultimately cumulative with the 
final intervention, most likely a critical control point (CCP), immediately before 
chilling.  
McEvoy et al. (82) reported a reduction in prevalence on carcasses after chilling 
for 24 h and hypothesized that chilling may stress the bacterial cells due to the 
synergistic effect of low Aw and temperature. Similarly, Gill et al. (50) reported a 
reduction in coliforms and E. coli on carcasses following cooling processes of between 
0.5 log10 units and 2 log10 units. As it pertains to food safety, the primary objective of 
chilling is to limit or slow growth of microorganisms; not necessarily to reduce their 
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numbers. When the carcass is processed and trimmed in to smaller cuts, the 
concentration of STEC should not increase if chill conditions are well controlled, but 
cross-contamination may occur to other cuts and surfaces with distribution of the 
pathogen throughout the ground meat.  
Research has been conducted for many chemical interventions applied to meat to 
reduce pathogens. Most of this research has focused on applications intended for use on 
the slaughter floor or on chilled subprimals and trimmings. In the early 1990s, hot water, 
chlorine and short chain organic acids were the most common sanitizing agents. Their 
effectiveness was dependent on the concentration used, temperature of the sanitizer, 
contact time, and the sensitivity of the microorganisms to the specific compound (31).  
 Some current chemical antimicrobial interventions include: polyphosphates, chlorine, 
cetylpyridinium chloride (CPC), sodium metasilicate (SMS), lactic acid, peroxyacetic 
acid (PAA), hypobrombous acid, hydrochloric acid, acidified sodium chlorite (ASC), 
acetic acid, citric acid, as well as some blends of organic acids. Organic acids exhibit 
greatest antimicrobial efficacy in their undissociated form, as this form facilitates greater 
penetration of the lipid bilayer of the cell membrane. Once inside the cell, the acid 
molecules begin to dissociate because of the near neutral pH of the cytoplasm. In an 
attempt to re-balance the cytoplasmic pH, the cell must use adenosine triphosphate 
(ATP) to pump protons out of the cell across the cytoplasmic membrane, depleting the 
cell of its energy source (29). Some organic acid treatments have been shown to be more 
effective at reducing bacterial contamination on adipose tissues compared to lean tissue 
(28, 53). After application of organic acid, the adipose tissue surface pH does not return 
  18 
to normal as soon as it may for lean surfaces, thereby creating an environment that is 
unfavorable for most pathogens (30, 53). However, Cutter and Siragusa (28) reported 
that the surface pH of acid treated lean tissue did not differ from untreated pieces 24 h 
after acid application. Dickson (30) theorized that the pH differences between the lean 
and adipose tissues were likely due to acid dilution caused by differences in lean and 
adipose tissue water content, 75% and 20%, respectively, or even different buffering 
mechanisms. 
2.8.1 Lactic Acid Solutions 
Lactic acid can be applied to beef carcasses, subprimals, and trimmings at a 
range of 2.0% to 5.0% concentration, and shall not exceed a temperature of 55°C, 
according to FSIS Directive 7120.1 (116). Hardin et al. (53) found water washing 
followed by 2.0% organic acid solution (55°C) significantly reduced E. coli O157:H7 
and Salmonella Typhimurium on beef. Furthermore, reduction of E. coli O157:H7 was 
greatest for those receiving the lactic acid spray compared to those that received the 
acetic acid spray (53). Harris et al. (55) found no difference among organic acid types or 
concentration (lactic or acetic; 2.0% or 4.0%) and acidified sodium chlorite sprays in 
their ability to reduce E. coli O157:H7 and Salmonella Typhimurium on beef trim. 
However, ground beef samples from the acidified sodium chlorite treated trimmings 
generally had a greater amount of E. coli O157:H7 present. Yoder et al. (123) stated 
organic acids including lactic acid are generally more effective as concentration 
increases from 1.0 to 5.0%. Lactic acid and acetic acid sprays did not differ statistically 
in their ability to reduce Salmonella Typhimurium in the Hardin et al. (53) study. 
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However, a study conducted by Anderson et al. (3), showed 3.0% lactic acid was more 
effective than acetic acid at reducing Salmonella Typhimurium on inoculated beef 
muscle cores. In fact, the 3.0% lactic acid treatment was the most effective acid 
treatment for reducing Salmonella Typhimurium at all application temperatures (20°C, 
45°C, and 70°C) (3). Furthermore, reduction of Salmonella Typhimurium increased as 
lactic acid application temperature increased. A 2.0 log reduction of Salmonella 
Typhimurium was achieved using the 3.0% lactic acid (70°C) dip, while reductions 
between 1.0 and 1.5 log were still achieved with the 20°C and 45°C lactic acid 
applications (3). Castillo et al. (21) found application of a 2.0% lactic acid solution 
(55°C) following a water wash to inoculated pre-chilled beef rounds reduced E. coli 
O157:H7 and Salmonella Typhimurium by 5.2 log cycles each. Additionally, the ground 
beef produced from products that received a pre-chill and post-chill acid spray, presented 
lower pathogen levels (21). Application of a 4.0% lactic acid solution (55°C) to chilled, 
inoculated beef rounds reduced E. coli O157:H7 and Salmonella Typhimurium an 
additional 2.0 and 1.6 log cycles, respectively. King et al. (74), reported that 2% solution 
of lactic acid reduced E. coli O157:H7 and Salmonella Typhimurium counts on beef 
carcasses while entering the chilling cooler, and prevented growth during the chilling 
period. In another study by Castillo et al. (17), 2.0% lactic acid spray in combination 
with hot water (95ºC at the source) had higher log reductions of E. coli O157:H7 and 
Salmonella Typhimurium than independent treatments. Cutter and Siragusa (28) 
reported a 2.6 log reduction in E. coli O157:H7 on beef carcass tissues following a 5.0% 
lactic acid (24°C) spray treatment. Heller et al. (56) observed a 1.1 log reduction of E. 
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coli O157:H7 on inoculated outside rounds destined for moisture enhancement or blade 
tenderization after application of a 5.0% lactic acid (55°C). Kalchayanand et al. (65) 
demonstrated that hot water (85°C), followed by lactic acid (4.0%) were the most 
effective at reducing STEC compared to 6 other treatment groups. Because lactic acid 
has been shown to effectively reduce E. coli and Salmonella across many different 
applications and parameters, it has become a very common intervention implemented by 
numerous beef processors. Regarding the vacuum storage after lactic acid spray on beef 
subprimals, the treatment improved the microbiological quality of meat for 14, 28, 56, 
84, and 126 days of vacuum storage (96). In a recent study, lactic acid was evaluated as 
an initial and secondary subprimal intervention for E. coli O157:H7, non-O157 STECs, 
and a nonpathogenic E. coli surrogate (94). In that study, initial use of lactic acid was 
validated as a subprimal intervention during beef fabrication followed by a secondary 
application to a vacuum-packaged product. As a result, total inoculum counts were 
reduced from 6 log CFU/cm2 to 3.6, 4.4, and 4.4 log CFU/cm2 for the E. coli surrogates, 
E. coli O157:H7, and non-O157 STEC inoculation groups, respectively (94). Following 
the second application, total inoculum counts were 2.6, 3.2, and 3.6 log CFU/cm2 for 
the E. coli surrogates, E. coli O157:H7, and non-O157 STEC inoculation groups, 
respectively. This study concluded that lactic acid treatments significantly lowered 
counts of pathogenic and nonpathogenic strains of E. coli on beef subprimals (94). In a 
different study, lactic acid spray was used to reduce the translocated E. coli O157:H7 
and Salmonella Typhimurium DT 104 in inoculated USDA Choice strip loins (53). In 
this study, lactic acid spray before mechanical tenderization or enhancement reduced E. 
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coli O157:H7 and Salmonella Typhimurium DT 104 loads up to 3.0 and 2.3 log10, 
respectively (37).  
2.8.2 Citric, Acetic, and Peroxyacetic Acid Solutions 
 Currently, there are several antimicrobial solutions on the market that utilize a 
blend of organic acids for use on particular products. Examples of some of these blends 
are as follows: Beefxide® (lactic acid and citric acid blend, Birko Corporation, 
Henderson, CO), Citrilow™ (citric acid and hydrochloric acid blend, Safe Foods 
Corporation, Little Rock, AR), Inspexx™-150 (acetic acid, peroxyacetic acid, and 
hydrogen peroxide blend; Ecolab, St. Paul, MN) and Inspexx™-200 (acetic acid, 
peroxyacetic acid, hydrogen peroxide, octanoic acid, and peroxyoctanoic acid blend; 
Ecolab, St. Paul, MN) 
Pohlman et al. (95) found that beef cuts treated with Citrilow™ had the lowest 
counts of E. coli and coliforms for day 1 and 2 of retail display. Laury et al. (76) 
conducted a trial in which beef trim was treated with either water (control) or 
Beefxide®, and was then swabbed to determine the final pathogen load. Findings 
suggested Beefxide® significantly reduced E. coli O157:H7 by 1.4 log CFU/ 100 cm², 
and Salmonella by 1.1 log CFU/100 cm², as compared to the control samples. A study 
conducted by Hendricks et al. (57) evaluated the effectiveness of 2.9% lactic acid and 
2.4% Beefxide® applied to beef cuts using a commercial spray cabinet. After application 
of an antimicrobial, each product was passed through a blade tenderizer. Lactic acid 
treatments had a 1.3 log reduction while Beefxide® treatments had a 1.4 log reduction. 
These researchers concluded that lactic acid and Beefxide® were similar in the 
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efficiency of reducing E. coli in the production of non-intact beef products. Cutter and 
Siragusa (28) found while acid concentrations 1.0%, 3.0%, and 5.0% had varying effects 
on pathogen reductions, there was no difference in efficacy between acetic, lactic, and 
citric acid solutions.  
The active component of buffered vinegar is acetic acid, which is appearing 
frequently as a natural preservative in processed meat as well as in poultry products. 
Typical household vinegar has a pH of 2.0-3.0. In one trial, 2.0% acetic acid was applied 
to beef flank sections before chilling and the treatment was able to reduce E. coli 
O157:H7 by 0.65 log CFU/cm2 and Salmonella by 0.87 to 0.91 log CFU/cm2 (7). In 
another study, beef carcasses were treated with 2% acetic acid spray or acetic acid plus 
pulsed-power electricity treatment, which significantly reduced the incidence of E. coli 
O157:H7 and caused a 1-log CFU/cm2 reduction of Salmonella Typhimurium (109).  
Certain peroxyacetic acid solutions permitted for use as antimicrobials on red 
meat carcasses and parts are listed in FSIS’s Directive 7120.1 (116). Yoder et al. (123) 
conducted a study which tested the efficacies of 8 chemical sprays to reduce pathogens 
on meat surfaces. The 8 chemicals used in the study were citric acid, lactic acid, acetic 
acid, peroxyacetic acid, acidified sodium chlorite, chlorine dioxide, sodium 
hypochlorite, and ozone-enriched water. Yoder et al. (123) reported that a 200 ppm 
peroxyacetic acid solution reduced E. coli O157:H7 and Salmonella Typhimurium 0.44 
and 1.03 log CFU/cm2, respectively. Although reductions were accomplished, these 
reductions did not differ from those achieved using tap water alone. All other treatments 
were more effective than the 200 ppm peroxyacetic acid solution at reducing E. coli 
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O157:H7 and Salmonella Typhimurium, with acetic acid, lactic acid, and citric acid 
being the 3 most effective. Penney et al. (93) studied the efficacy of peroxyacetic acid 
and water washing to control E. coli O157:H7 on beef and bob veal carcasses. 
Treatments evaluated in the study were: 180 ppm peroxyacetic acid, water wash, and 
water wash followed by 180 ppm peroxyacetic acid wash. Water washing followed by 
peroxyacetic acid spray resulted in reductions of 2.73 and 3.21 log CFU/cm2 of E. coli 
O157:H7 on veal and beef, respectively. The peroxyacetic acid treatment alone was most 
effective at reducing E. coli O157:H7 on veal and beef with reductions of 3.56 and 3.59, 
respectively. King et al. (74) evaluated the effects of peroxyacetic acid and its ability to 
reduce E. coli O157:H7 and Salmonella Typhimurium on beef carcasses. Multiple 
variables including peroxyacetic acid treatment before or after chilling, following a 
water wash, and at different concentrations and application temperatures were evaluated. 
Application of 200 ppm peroxyacetic acid to chilled beef resulted in no reduction of E. 
coli O157:H7 or Salmonella Typhimurium. Application of 200 ppm peroxyacetic acid to 
hot beef carcasses resulted in 0.7 log CFU/cm2 reduction of E. coli O157:H7 and 
Salmonella Typhimurium (74). 
2.8.3 Other Chemical Antimicrobials 
 Cetylpyridinium chloride (CPC) is a water-soluble compound that has been used 
for more than 50 years in oral hygiene products. CPC is a quaternary ammonia, which 
kills or injures cells by disruption of the cytoplasmic membrane, resulting in leakage of 
cell constituents. This compound has a low surface tension with hydrophilic and 
lipophilic properties which allows it to work well to hydrate and penetrate tissue (61, 
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85). CPC has been effective for reducing Salmonella contamination of poultry carcasses 
(73, 121, 122) as well as for preventing cross-contamination during poultry slaughter. 
However, CPC is not currently approved for use on any beef product other than hide-on 
washes (116). There have nonetheless been several trials that have researched the 
efficacy of CPC in several different application scenarios. In a study by Cutter et al. (27) 
examining spray-washing lean beef surfaces with 1.00% CPC, this compound reduced 5 
to 6 log10 CFU/cm2 of inoculated E. coli O157:H7 and Salmonella Typhimurium to 
practically undetectable levels (0 log10 CFU/cm2). This same study on adipose beef 
surfaces also reduced 5 log10 CFU/cm2 of inoculated E. coli O157:H7 and Salmonella 
Typhimurium immediately (>2.5 log10 CFU/cm2). Ransom et al. (98) demonstrated that 
0.5% CPC applied to beef surfaces and trimmings resulted in the best reductions of E. 
coli O157:H7 (4.8 log10 CFU/cm2 and 2.1 log10 CFU/cm2 for beef carcass tissues and 
lean tissue pieces, respectively) when compared to other commonly used antimicrobials. 
In another trial in the same laboratory, Stopforth et al. (106) observed the greatest 
reductions of E. coli O157:H7 by using CPC solutions in a spray-chilling application. 
Byelashov et al. (15) found 0.50% CPC included as a brine ingredient in moisture-
enhanced beef resulted in the lowest overall counts of pathogens when compared to the 
other treatments. Sodium metasilicate (SMS) solutions have a strong alkalinity (pH of 
12.3 at 1.00% solution) and have demonstrated efficacy for reduction of pathogens 
(118). Several trials have been conducted that support utility of SMS and CPC as 
antimicrobial ingredients to reduce microorganisms in beef (2, 44-46, 83). Adler et al. 
(2) reported either significant reductions or no detectable E. coli O157:H7 in samples 
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using CPC or SMS as a brine ingredient. Mehall et al. (83) found beef cuts in the CPC 
and SMS treatments had the lowest counts of APC and coliforms at day 2 of retail 
display. Continued investigation of the application methods for these compounds is 
necessary to fully understand their capabilities.   
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CHAPTER III 
MATERIALS AND METHODS 
 
3.1 Meat Selection 
 Various cuts of beef were used for the trials described in this chapter. For one 
experiment, beef briskets, deckle off, boneless (IMPS# 120) were collected from a local 
harvest facility to acquire pre-chilled product. All other beef was purchased as vacuum-
packaged, boxed beef and were stored (2°C) until time of use. The following cuts were 
used throughout the trials using the Institutional Meat Purchase Specifications (IMPS) of 
the USDA (110) to describe them: beef round, bottom round flats (IMPS# 171B); beef 
loin, top sirloin butt, boneless (IMPS# 184); beef loin, strip loin, boneless (IMPS# 180); 
round, sirloin tip (knuckle), peeled (IMPS# 167A); beef loin, short loin (IMPS# 173); 
beef chucks, chuck roll (IMPS# 116A); beef rounds, (top) inside (IMPS# 169); beef loin, 
bottom sirloin butt, tri-tip, boneless (IMPS# 185C); and beef trimmings (80/20) (IMPS# 
138).  
3.2 Microbiological Selection and Preparation Methods 
Five nonpathogenic E. coli Biotype I (Non-RifR) strains (BAA-1427, BAA-1428, 
BAA-1429, BAA-1430, and BAA-1431) were obtained from the American Type Culture 
Collection (Manassas, VA, USA). Three of these strains (BAA-1427, BAA-1428, and 
BAA-1430) then were selected in the Food Microbiology Laboratory at Texas A&M 
University for their inherent ability to naturally resist rifampicin (RifR) using the 
methods published by Kaspar and Tamplin (70). For this research, either a combination 
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of the 5 non-rifampicin-resistant strains, or a combination of the 3 rifampicin-resistant 
(RifR) strains were used, depending on the trial. Previous research (16, 81) has validated 
that these microorganisms demonstrate similar thermal and lactic acid resistance 
properties to the human pathogen E. coli O157:H7. These marker microorganisms were 
combined into a “cocktail” to represent possible contamination with enteric pathogens of 
fecal origin such as E. coli O157:H7.  
Cocktail preparation began 48 h before each day of the trial; cultures of E. coli 
(parent strains of BAA-1427, BAA-1428, BAA-1429, BAA-1430, and BAA-1431 for 
the Non-RifR cocktail; and rifampicin-resistant strains of BAA-1427, BAA-1428, and 
BAA-1430 for the RifR cocktail) were proliferated by aseptically transferring a loop of 
the microorganism from a tryptic soy agar (TSA, Becton, Dickinson and Co., Sparks, 
MD) slant to a sterile 10 ml tryptic soy broth (TSB, Becton, Dickinson and Co., Sparks, 
MD) tube and incubating aerobically (35°C) for 18 to 24 h. Following incubation, each 
strain was transferred individually by depositing a loop of the solution containing the 
microorganisms from its 10 ml TSB tube into a new 10 ml TSB before incubating 
aerobically at 35°C for 18 to 24 h. After incubation, the cultures were ready to either be 
used as a cocktail, or further prepared as a pellet. The cocktail preparation method was 
the method by which microorganisms were prepared for inoculation in the lab.  
The pellet preparation method was the method by which the microorganisms 
were prepared for transport and use for the in-plant inoculation portions of the study. To 
prepare the pellet, the tubes from each culture were combined in a 50 ml Falcon™ 
(Thermo-Fisher Scientific, Waltham, WA) conical centrifuge tube and cells were 
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collected by centrifugation at 2,205 x g for 15 min. The supernatant then was decanted 
and the pellet was re-suspended in 30 ml of 0.1% (w/v) peptone diluent. These washing 
and re-suspension procedures were repeated twice more identically. The final pellets 
were stored (2°C) for 2-8 days (depending on experiment) until needed for inoculation 
use. Before use as inoculum, pellets were re-suspended in 30 ml (30 ml for RifR; 50 ml 
for Non-RifR) of 0.1% (w/v) peptone diluent. 
3.3 Product Inoculation, Sampling, and Microbiological Analysis 
For each experiment, background microbiological samples (3MTM Sponge-Stick 
with Buffered Peptone Water Broth, 3M Food Safety, St. Paul, MN) of the exterior 
surface of randomly selected beef cuts were taken to verify that no existing rifampicin-
resistant (when applicable) microorganisms were present before inoculation.  
Inoculation methods were based on product type and volume needed for 
complete coverage of the surface. In experiments using whole beef cuts, inoculum was 
applied via handheld sprayer. For cutlets and trimmings, the beef was separated into 
batches and was placed into sterile zippered-top bags and inoculation was conducted by 
adding inoculum to the zippered-top bag, and hand tumbling for 1 min to completely 
cover all pieces with the inoculum. Inoculum volumes were based on complete coverage 
of the surface. For all experiments, pre-treatment surface samples were collected after a 
30-minute attachment time was observed to allow for attachment of surrogate E. coli to 
meat surfaces. Post-treatment surface samples were collected approximately 5 min after 
application of the antimicrobial intervention (when applicable). For each sample, 5 
surface tissue excisions (10 cm2 x 2 mm deep) were collected via sterile stainless-steel 
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borer, scalpel, and forceps. Surface excisions were composited (50 cm2, total sampled 
area) in a sterile stomacher bag with 100 ml sterile diluent (0.1% peptone [w/v]) and 
were pummeled for 1 minute at 260 rpm using a stomacher (Stomacher-400, Tekmar 
Company, Cincinnati, OH). 
For beef trimmings and cutlets, a sample (50 g composite) was taken randomly 
from the surfaces of the pieces by use of sterile stainless-steel scalpel and forceps. The 
composite sample was placed in a sterile stomacher bag with 100 ml sterile diluent 
(0.1% peptone [w/v]) and pummeled for 1 minute at 260 rpm using a stomacher. 
For beef tri-tips used in moisture-enhanced experiments, surface samples were 
collected by excising 5 (3 from 1 side, 2 from the opposite side) 10 cm2 x 2 mm deep 
pieces by use of sterile stainless-steel borer, scalpel, and forceps, creating a composite 
sample of 50 cm2 sample area. After tumbling, surface samples (50 cm2 total) and 1 
internal ‘core’ sample was taken from each cut using a sterile stainless-steel borer. The 
top and bottom surfaces of the core sample were discarded and the exterior surface of the 
core was flame-sterilized by immersing the core sample in 95% ethanol and flame 
sterilizing the outside surface so only the surviving internalized microorganisms were 
quantified. Core samples then were placed in a sterile stomacher bag, sterile diluent 
(0.1% peptone [w/v]) was added, and samples were pummeled for 1 minute at 260 rpm 
using a stomacher. 
All samples were plated with a sterile bent glass rod using the appropriate serial 
dilutions onto pre-poured and dried agar plates. For trials using Non-RifR cultures, 
samples were plated onto pre-poured and dried tryptic soy agar (TSA)-loaded Petri 
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dishes, overlaid with 12 ml MacConkey Agar (Becton, Dickinson and Co., Sparks, MD), 
and were aerobically incubated 48 h (35°C). For trials using RifR cultures, samples were 
plated onto pre-poured and dried rifampicin-tryptic soy agar (Rif-TSA, Difco, Becton, 
Dickinson and Co., Sparks, MD) Petri dishes. Before sample collection, Rif-TSA was 
prepared by adding a solution of 0.1 g of rifampicin (Sigma-Aldrich, St. Louis, MO) 
dissolved in 5.0 ml of methanol to 1 liter of autoclaved and tempered (55°C) TSA. Once 
the samples were plated, Rif-TSA plates were incubated (35°C) for 24 h. For all 
samples, colonies were inspected, counted, recorded, transformed, and reported as log10 
CFU.  
3.4 Antimicrobial Solution Preparation Methods 
For laboratory experiments, lactic acid (88% L-lactic acid, Purac® FCC 88, 
Corbion, Lenexa, KS) solutions were prepared by diluting the 88.0% stock solution into 
deionized water to achieve the appropriate concentrations for each experiment. Acid 
titrations were conducted per the manufacturer’s directions using the supplied test kit to 
confirm proper lactic acid concentrations. Titrations were performed by pipetting 1 ml of 
lactic acid test solution in to a clean test tube. Next, 1 drop of phenolphthalein indicator 
solution was added. Finally, individual drops of 0.25 N sodium hydroxide were added 
and then shaken to stir the solution until the test solution turned from clear to pink in 
color. The number of sodium hydroxide drops added was recorded and divided by 10 to 
calculate the percent lactic acid concentration. 
Citrilow™ (pH = 1.05, Safe Foods Corporation, Little Rock, AR) solutions used 
in laboratory experiments were prepared according to manufacturer’s instructions by 
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mixing with deionized water, and pH was verified using a calibrated pH meter 
(sympHony pH meter, VWR, Suwannee, GA)  
The in-plant preparation of the concentrations of antimicrobial solutions (lactic 
acid, Beefxide® [2.0% at 41ºC, Birko Corporation, Henderson, CO], Citrilow™, and 
peroxyacetic acid solutions [Inspexx™-150 and Inspexx™-200, Ecolab, St. Paul, MN]) 
were performed according to manufacturers’ recommendations by the plant personnel to 
ensure it was the same as their daily preparation. 
3.5 Preliminary Trials 
Before conducting the in-plant portion of the study, several trials were conducted 
to establish methods to prepare and transport the microorganisms from the laboratory for 
use in a federally inspected processing facility.  
3.5.1 Culture Viability in “Pellet” Form 
Fourteen (n = 14) sets of RifR pellets were created for this experiment and stored 
at 2°C until re-suspended for plating. Starting on the second day of storage, 2 pellets 
were plated each day for 7 consecutive days. Colonies were counted, recorded, and 
transformed and reported as log10 CFU/ml.  
3.5.2 Non-RifR Cocktail vs. Pellet #1 
Three beef bottom round flats were used. Each bottom round flat was divided 
into 2 portions and each portion was assigned to one of the 2 different inoculum 
preparation methods used (n = 6).  
For this experiment, Non-RifR cocktail and pellet inocula were used. Inocula (9.2 
& 9.1 log10 CFU/cm2 for cocktail & pellet, respectively) were sprayed onto beef (2 ml) 
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using a hand-held sprayer. Following 30-min attachment period, lactic acid (15 ml, 3.5% 
± 0.1% at 25°C) was applied to the inoculated beef using a hand-held sprayer. Pre-
treatment and post-treatment surface excisions were collected for enumeration of 
surrogate E. coli. 
3.5.3 Non-RifR Cocktail vs. Pellet #2 
Six beef bottom round flats were used. Each bottom round flat was divided into 2 
portions and each portion was assigned to either the cocktail or the pellet group (n = 12).  
For this experiment, Non-RifR cocktail and pellet inocula were used. Of the 6 
cuts assigned to each inoculum preparation group, 3 cuts were treated with Citrilow™, 
and 3 were treated with lactic acid. Inocula (9.2 & 9.1 log10 CFU/cm2 for cocktail & 
pellet, respectively) were spray-applied onto beef (2 ml delivered vol.) using a hand-held 
sprayer. Following a 30-minute attachment time, lactic acid (15 ml, 3.5% ± 0.1% at 
25°C) or Citrilow™ (15 ml, pH 1.05 ± 0.02, 25°C) were sprayed onto inoculated beef. 
Pre-treatment and post-treatment surface excisions were collected for enumeration of 
surrogate E. coli. 
3.5.4 RifR Cocktail vs. Pellet 
For this trial, 6 beef bottom round flats were used. Each bottom round flat was 
divided into 2 portions and each portion was assigned to either the cocktail or the pellet 
group (n = 12). RifR cocktail and pellet inocula were used for this trial.  
Of the 6 cuts assigned to each inoculum preparation group, 3 cuts were treated 
with Citrilow™ and 3 were treated with lactic acid. Inocula (9.2 & 9.1 log10 CFU/cm2 
for cocktail & pellet, respectively) were spray-applied onto beef (2 ml delivered vol.) 
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using a hand-held sprayer. Following a 30-minute attachment time, lactic acid (15 ml, 
3.5% ± 0.1% at 25°C) or Citrilow™ (15 ml; pH 1.05 ± 0.02, 25°C) were sprayed onto 
inoculated beef. Pre-treatment and post-treatment surface excisions were collected for 
enumeration of surrogate E. coli. 
3.5.5 Pre-chill vs. Post-chill  
Twenty-four (n = 24) pre-chilled beef briskets were obtained for this trial. 
Twelve briskets were assigned to the “post-chill” group and placed on ice in insulated 
coolers for transport and were stored (2°C) for 24 h. The remaining 12 briskets assigned 
to the “pre-chill” group were kept warm in an insulated container and transported to the 
Food Microbiology Laboratory at Texas A&M University. Upon arrival, the fat side 
(exterior of the carcass) of each cut was inoculated with 6 ml of the RifR cocktail. The 
log10 CFU/ml of initial inoculum cocktail was high enough (8.0 to 9.0 log CFU/ml) to 
ensure enough microorganisms could be recovered from the product, before and after the 
antimicrobial intervention. After inoculation, the “pre-chill” briskets were placed on a 
metal rack in refrigerated storage (4°C) for 24 h. After 24 h of chilling, the “post-chill” 
briskets were inoculated according to the methods described for the “pre-chill” briskets. 
For both “pre-chill” and “post-chill” briskets, temperature (28°C and 4°C, respectively) 
was recorded at the time of inoculation and at the time of antimicrobial treatment. 
Following collection of the pre-treatment samples, the 12 cuts (3 briskets per treatment) 
were subjected to approximately 100 ml spray of one of 4 treatments: 55°C lactic acid, 
25°C lactic acid, 55°C Citrilow™, or 25°C Citrilow™ (lactic acid, 3.5% ± 0.1%; 
Citrilow™, pH 1.05 ± 0.05). Pre-treatment and post-treatment surface excisions were 
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collected for enumeration of surrogate E. coli. After chilling for 24 h, the “pre-chill” 
briskets were removed from refrigerated storage, sampled and treated according to 
methods described for the “post-chill” briskets. Pre-treatment and post-treatment surface 
excisions were collected for enumeration of surrogate E. coli. 
3.6 In-Plant Validation of Antimicrobial Interventions to Reduce Escherichia coli 
Texas A&M University worked with establishments in Nevada and Pennsylvania 
to complete the in-plant trials of this project. Both establishments are federally 
inspected, so the project was designed to comply with all USDA regulatory requirements 
related to process validation and use of surrogate microorganisms. According to USDA-
FSIS (115), “an establishment that chooses to conduct a validation study may use a 
surrogate indicator organism to measure change, but it should do so only after giving 
careful consideration to specific precautions. These precautions include ensuring that a 
properly trained individual introduces the non-pathogenic cultures within the 
establishment. In addition, the establishment should ensure that the introduction of the 
non-pathogenic cultures does not create an insanitary condition in the facility or cause 
the food to become adulterated. Finally, establishments should ensure that the non-
pathogenic cultures are necessary and proven to be effective for the intended purpose.” 
“To better ensure insanitary conditions are not created, establishments are 
encouraged to apply surrogate indicator organism cultures in a manner to ensure that the 
establishment can conduct a full cleaning and sanitizing of the facility and equipment 
after the stage in the food safety application being evaluated. Generally, product 
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containing the surrogate indicator organism cultures would not automatically be 
considered adulterated.” 
To conduct this investigation, normal processing procedures were simulated on 
Saturday or Sunday when no other production was in process. This was to ensure 
sanitary conditions were maintained, products were controlled, and there was no 
potential for cross-contamination with non-experimental products. The processing 
environments were sampled before and after the validation to ensure no preexisting 
and/or residual contamination existed.  
Beef cuts (whole subprimals) were selected by the establishment based on 
production volume. This trial focused on validating the efficacy of the application of the 
anti-microbial interventions such as lactic acid, Beefxide, Citrilow™, and peroxyacetic 
acid. The interventions were validated using processing parameters implemented by the 
commercial processing establishment.  
3.6.1 In-Plant Trial #1 
Eight cuts of each top sirloin, strip loin, knuckle, and short loin were used for this 
trial. The 8 cuts of each type were divided into 2 treatment groups: Inspexx™ 150 (150 
ppm at 13°C) (4 cuts of each type) and Inspexx™ 200 (190 ppm at 13°C) (4 cuts of each 
type). Top sirloin and strip loin were treated with top sprayers only, whereas knuckle 
and short loin were treated with top and bottom sprayers. Top sirloin and strip loin cuts 
were inoculated on the fat (exterior of the carcass) surface with 6 ml of inoculum from 
the RifR pellet. The log10 CFU/ml of initial inoculum cocktail was great enough (8.0 to 
9.0 log10 CFU/ml) to ensure a sufficient number of microorganisms can be recovered 
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from the product, before and after the antimicrobial intervention. Knuckle and short loin 
cuts were inoculated on the top and bottom surfaces of each cut with the cocktail; 6 ml 
per side. Pre-treatment and post-treatment surface excisions were collected for 
enumeration of surrogate E. coli. Each sample was placed in a sterile Whirl-Pak bag 
(Nasco, Atlanta, GA) and stored inside an insulated container with coolant packs, and 
transported to the Food Microbiology Laboratory at Texas A&M University.  
3.6.2 In-Plant Trial #2 
 Twelve cuts of each striploin and knuckle were used for this trial. The 12 cuts of 
each type were divided into 3 treatment groups: Inspexx™ 150 (150 ppm at 19°C) (4 
cuts of each type), Inspexx™ 200 (190 ppm at 23°C) (4 cuts of each type), and 
Beefxide® (2.0% ± 0.1% at 41°C) (4 cuts of each type). Each of the beef surfaces were 
sprayed with 6 ml of inoculum from the RifR pellet for this trial. All cuts were treated 
with top and bottom sprayers. Pre-treatment and post-treatment surface excisions were 
collected for enumeration of surrogate E. coli. 
3.6.3 In-Plant Trial #3 
 For this trial, the following types of beef cuts were used: 4 chuck rolls, 4 inside 
rounds, 8 bottom round flats, 8 sets of cutlets from the bottom round, and 8 units of beef 
trimmings. Each of the beef cuts were sprayed with 6 ml of inoculum from the Non-RifR 
pellet for this trial. Pre-treatment and post-treatment surface excisions were collected for 
enumeration of surrogate E. coli.  
For cutlets and trimmings, the beef was separated into 1 kg batches and was 
placed into sterile zippered-top bags and inoculation was conducted by adding 100 ml of 
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the Non-RifR pellet inoculum to the zippered-top bag, and hand tumbling for 1 min to 
completely cover all pieces with the inoculum. Pre-treatment and post-treatment surface 
excisions were collected for enumeration of surrogate E. coli. 
All beef cuts, including cutlets, were treated with top and bottom sprayers. For 
beef trimmings, 4 units were treated using 2 different augers and their sprayers. Beef 
trimmings, as well as whole beef cuts, were treated with Citrilow™ (pH 1.05 ± 0.05 at 
25°C). Beef cutlets were treated with lactic acid (3.5% ± 0.1% at 25°C).  
3.6.4 In-Plant Trial #4 
For this trial, the following types of beef cuts were used: 8 chuck rolls, 8 bottom 
round flats, and 8 bottom round roasts. Bottom round roasts was prepared by removing 
all fat and connective tissue from the surface of the original cut with a boning knife, to 
expose 100% of the lean muscle tissue. Each of the beef surfaces were sprayed with 6 ml 
of inoculum from the RifR pellet. All cuts were treated with top and bottom sprayers. 
Chuck rolls and outside rounds were treated with Citrilow™ (pH 1.05 ± 0.05 at 25°C). 
Bottom round roasts were treated with lactic acid (3.5% ± 0.1% at 25°C). Pre-treatment 
and post-treatment surface excisions were collected for enumeration of surrogate E. coli. 
3.6.5 Water Comparison Trial 
 A trial was conducted using water from one of the processing facilities to prepare 
antimicrobial solutions for application onto beef cuts. The purpose was to determine if 
there was any difference in the efficacy of the antimicrobial solutions based on the 
source of the water used to prepare them. 
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Twenty-four beef bottom round flats were used. Six bottom rounds were used for 
each of the 4 replications. For each replication, each of the bottom rounds were cut in 
half, creating 12 individual units. Three of the cuts were assigned to each of the 4 
treatment groups. A RifR cocktail was used for this experiment. The fat side (exterior of 
the carcass) of each cut was inoculated with 6 ml of the cocktail to ensure complete 
coverage of the surface. The log10 CFU/ml of initial inoculum cocktail was great enough 
(8.0 to 9.0 log10 CFU/ml) to ensure a sufficient number of microorganisms could be 
recovered from the product, before and after the antimicrobial intervention. Treatment 
solutions were prepared using either deionized water from the TAMU laboratory 
(TAMU) or water from a meat processing establishment in Pennsylvania (PA). 
Following collection of the pre-treatment samples, the 12 cuts (3 per treatment) were 
subjected to approximately 100 ml spray of one of 4 treatments: (TAMU-lactic acid, 
TAMU-Citrilow™, PA-lactic acid, and PA-Citrilow™) (Lactic Acid, 3.5% ± 0.1%) 
(Citrilow™, pH 1.05 ± 0.05). Pre-treatment and post-treatment surface excisions were 
collected for enumeration of surrogate E. coli. 
3.7 Evaluation of the Use of Lactic Acid to Reduce Escherichia coli on Frozen Beef 
Surfaces  
3.7.1 Frozen Trimmings 
Beef inside rounds were fabricated into small pieces to create beef trimmings. 
For each of the 3 replications, beef trimmings were weighed and segregated into three 
1.2 kg batches for inoculation.  
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The log10 CFU/ml of initial inoculum cocktail was high enough (8.0 to 9.0 log10 
CFU/ml) to ensure a sufficient number of microorganisms could be recovered from the 
product both before and after the antimicrobial intervention. Once segregated, each of 
the 1.2 kg batches of beef trimmings were placed into sterile zippered-top bags and were 
inoculated with a RifR cocktail. Inoculation was conducted by adding 120 ml (to 
completely cover the surface) of the cocktail to the zippered-top bag, and hand tumbling 
for 1 min to completely cover all pieces of trimmings with the inoculum. Once 
inoculated, the 1.2 kg batches were divided into two 600 g units of trimmings and 
assigned to one of the 2 treatments. Post-inoculation (before freezing), pre-treatment 
(after freezing), and post-treatment surface excisions were collected for enumeration of 
surrogate E. coli. Samples were taken from each of the 600 g units by use of sterile 
stainless-steel scalpel and forceps, creating a composite sample of 50 g. Each unit of 
trimmings was stored in a freezer (-20°C) for approximately 24 h. After freezing, 
trimmings were tempered (15 min at 25°C), broken apart, and sampled (50 g surface). 
Immediately after sampling, trimmings were subjected to warm (55°C) lactic acid 
(prepared from 88.0% L-lactic acid) spray (10 ml delivered vol) using a hand-held 
sprayer. Lactic acid solutions were heated by circulating hot water around the solution 
container until the solution temperature reached the desired temperature (close to, but 
not exceeding 55°C) for application in this trial. Lactic acid was applied to the trimmings 
at either 2.5% or 5.0% concentration, depending on their treatment group assignments. 
Post-treatment samples then were collected. 
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3.7.2 Fresh vs. Frozen 
Beef bottom round flats were used. For each of the 4 replications, 6 bottom round 
flats split in half creating 12 individual pieces (48 total). These pieces then were trimmed 
to a smaller size (approx. 20 cm x 15 cm x 5 cm), while maintaining the original 
“medial” surface (near the attachment to the femur) of the bottom round. This was done 
so they could later be placed into containers for freezing. 
A RifR cocktail was used for this experiment. Six ml of inoculum was applied to 
completely cover of the surface. The log10 CFU/ml of initial inoculum cocktail was high 
enough (8.0 to 9.0 log10 CFU/ml) to ensure a sufficient number of microorganisms could 
be recovered from the product both before and after the antimicrobial intervention. The 
12 units were assigned to 4 separate lactic acid treatment groups (3 units per treatment): 
fresh - 2.5% lactic acid, fresh - 5.0% lactic acid, frozen - 2.5% lactic acid, and frozen - 
5.0% lactic acid. The units assigned to the 2 “fresh” treatment groups were subjected to a 
spray of the designated lactic acid solutions (80 ml delivered vol, applied at 25°C), using 
a pump-up, garden-type sprayer. The units assigned to the 2 “frozen” treatment groups 
were placed into autoclaved aluminum foil pans, covered with foil, and stored in the 
freezer (-20°C) for approximately 24 h. After freezing, the cuts were tempered (15 min 
at 25°C), and were subjected to a spray of the designated lactic acid solutions (approx. 
80 ml, applied at 25°C), using a pump-up; garden-type sprayer. Pre-treatment and post-
treatment surface excisions were collected for enumeration of surrogate E. coli. 
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3.8 Evaluation of Antimicrobial Ingredients to Reduce Escherichia coli in Moisture 
Enhanced Beef Products 
3.8.1 Moisture Enhanced Preliminary Trial 
A preliminary trial using 4 beef tri-tips was conducted to determine if individual 
cuts could be vacuum tumbled while contained inside of a vacuum package, and if the 
packaging would have an impact on the internalization of the microorganisms within the 
product. Before inoculation, tri-tip roasts were trimmed to remove all exterior fat and 
connective tissue from the surfaces.  
A RifR cocktail was used for this experiment. Two ml of the inoculum was 
applied to completely cover the surface. The log10 CFU/ml of initial inoculum cocktail 
was high enough (8.0 to 9.0 log10 CFU/ml) to ensure a sufficient number of 
microorganisms could be recovered from the product after vacuum tumbling. Following 
attachment, surface samples were collected. This sample was collected to determine the 
pre-tumbling load of the applied microorganisms. Two of the cuts were vacuum 
packaged (KOCH Vacuum Packaging Machine, Kansas City, MO) and 2 of the cuts 
were left un-packaged. The cuts were placed in a BIRO vacuum tumbler Model 12 VTS-
42 (Biro MFG Co., Marblehead, OH). The product was tumbled for 30 min to simulate 
normal tumble marinating procedures. Post-tumbling core samples were collected. 
3.8.2 Marinated Trial #1 
Twenty-four beef tri-tips were used. Before inoculation, tri-tip roasts were 
trimmed to remove all exterior fat and connective tissue from the surfaces. Marinade 
formulation was REO - TAMU Fajita Marinade (REO Spice & Seasoning, Inc., 
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Huntsville, TX). The base marinade consisted of 240.0 g of REO marinade seasoning, 
26.4 g of sodium tripolyphosphate (STP, BK Giulini Corp., Simi Valley, CA) and 332.4 
ml of deionized water. For the treatment group, 3.0 g of cetylpyridinium chloride (CPC, 
0.02%, added as Cecure® 40.0% stock solution, Safe Foods Corp., North Little Rock, 
AR) were added to the marinade. Marinades were stirred using a hot plate/stirrer (no 
heat; VWR, Suwannee, GA). 
For each of the replications, 3 tri-tip roasts were assigned to the treatment (CPC) 
group and 3 were assigned to the control (CON) group. For the 3 tri-tip roasts in each 
group, one of them was sampled on day 0, 2, and 4 after marination. A RifR cocktail was 
used for this experiment. Two ml of the inoculum was applied to completely cover the 
surface. Weights for each tri-tip were recorded and marinade was added for a 10% 
moisture enhancement (e.g., 34 g marinade added to 340 g tri-tip). Marinated cuts were 
individually vacuum packaged and vacuum tumbled for 30 min. One of the 3 pieces in 
each treatment group was sampled immediately (day 0). The 2 remaining pieces of 
product were held at 4˚C to be sampled at 48 h and 96 h. Pre-treatment and post-
treatment surface excisions and internal core samples were collected for enumeration of 
surrogate E. coli. 
3.8.3 Marinated Trial #2 
Thirty-six beef tri-tips were used. Before inoculation, tri-tip roasts were trimmed 
to remove all exterior fat and connective tissue from the surfaces. A RifR cocktail was 
used for this experiment. Two ml of the inoculum was applied to completely cover the 
surface. 
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Marinade formulation was REO - TAMU Fajita Marinade. The base marinade 
consisted of 120.0 g of REO marinade seasoning, 13.2 g of sodium tripolyphosphate 
(STP) and 166.8 ml of deionized water. For the AvGard® (0.2%, sodium metasilicate 
added as AvGard® XP, Danisco USA, Inc., New Century, KS) treatment group, 6 g of 
AvGard® was added to the marinade. For the 0.05% and 0.10% CPC treatment groups, 
3.75 ml and 7.5 ml of CPC were added to the marinade, respectively. Marinades were 
stirred using a hot plate/stirrer. Weights for each tri-tip were recorded and marinade was 
added for a 10% moisture enhancement (e.g., 34 g marinade added to 340 g tri-tip). 
Marinated cuts were individually vacuum packaged and vacuum tumbled for 30 min. 
For each of the 3 replications, 3 tri-tip roasts were assigned to each of the 
treatment groups (Control, AvGard®, 0.05% CPC, and 0.10% CPC). All cuts were 
sampled after 4 days of storage at 4°C. Pre-treatment and post-treatment surface 
excisions and internal core samples were collected for enumeration of surrogate E. coli. 
3.9 Statistical Analysis 
Microbiological count data were transformed into logarithms before calculating 
means and performing statistical analysis. In the case of counts below the detection limit 
of the counting method (limit of detection [LOD] = 2.0 log10 CFU), a number (1.7 log10 
CFU) between 0 and the lowest detection limit was used to facilitate data analysis. All 
data were analyzed using JMP® Software (JMP Pro, v12.2, SAS Institute Inc., Cary, 
NC). The Fit Model function was used for analysis of variance (ANOVA), determining 
interactions from the full model. Least squares means comparisons were performed 
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using Tukey-Kramer honestly significant difference (Tukey’s HSD) tests with an α = 
0.05.  
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CHAPTER IV 
RESULTS AND DISCUSSION 
 
4.1 Preliminary Trials 
4.1.1 Pellet Viability 
Storing the pellets for up to 8 days had an impact (P < 0.05) on the concentration 
(log10 CFU/ml) of the microorganisms (Table 1). Days 2, 3, 4, 7, and 8 were not 
different. The reason for the slight decrease in concentration on days 5 and 6 is 
unknown, but we speculate that if this experiment were replicated with a greater number 
of samples, the difference in concentration across all 7 days would be minimized. These 
results suggest these cultures could be prepared as a pellet and stored (4˚C up to 8 days) 
for in-plant validation trials. 
4.1.2 Cocktail vs. Pellet 
There was no difference (P > 0.05) between starting (pre-treatment) microbial 
counts for cuts inoculated with the cocktail and those inoculated with the pellet in the 
first experiment (Table 2). Pre-treatment counts were different (P < 0.05) between the 
cuts inoculated with the cocktail and pellet for the second and third experiments (Table 3 
and 4, respectively). For all 3 cocktail vs. pellet experiments, there was no difference (P 
> 0.05) between reductions of microbial counts for cuts inoculated with the cocktail and 
those inoculated with the pellet. Finally, for the second and third experiments, there was 
no difference (P > 0.05) between reductions of microbial counts for cuts treated with 
Citrilow™ and those treated with lactic acid. 
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These results helped to establish the utility of cultures prepared for use in pellet 
form for in-plant validation trials. Analyses of data indicate method of pathogen 
surrogate preparation for in-plant food safety intervention validation impacted numbers 
of cells successfully inoculated onto experimental product surfaces. Method of inoculum 
preparation did not impact observed surrogate reductions following treatment. 
Researchers and industry specialists engaged in food safety intervention validation could 
benefit from the resulting data. 
4.1.3 Pre-chill vs. Post-chill 
There was no difference (P > 0.05) between reductions of E. coli for cuts 
inoculated pre-chilling and those inoculated after chilling (Table 5). Citrilow™ applied 
at 55ºC to pre-chill inoculated cuts resulted in greater reductions (P < 0.05) any of the 
groups treated with lactic acid (Table 6). These results indicating the efficacy of 
Citrilow™ agree with those presented by Pohlman et al. (95). Also, Castillo et al. (21) 
demonstrated that lactic acid sprays applied to both pre-chill and post-chill beef can 
reduce E. coli. 
This trial was conducted to determine the effects of “pre-chill” inoculation (to 
simulate contamination during the harvest process) versus “post-chill” inoculation of 
beef cuts while performing CCP validation in processing facilities and to determine if 
the temperature of the subsequent antimicrobial spray had an interaction with the 
inoculation temperature. These results suggest that chilled beef cuts can be inoculated 
and used during the validation of food safety interventions. 
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4.2 In-Plant Trials 
4.2.1 In-Plant Trial #1 
There was no difference (P > 0.05) between Inspexx™ 150 and Inspexx™ 200 
for reductions of surface E. coli. More favorable reductions were achieved on the top 
sirloins and strip loins (0.7 to 0.8 log10 CFU/50 cm2) than on short loins and knuckles 
(0.2 to 0.3 log10 CFU/50 cm2) (Table 6). Sirloins that were subjected to either of the 
treatments had better reductions (P < 0.05) than knuckles treated with Inspexx™ 150. 
4.2.2 In-Plant Trial #2 
There was no difference (P > 0.05) in reductions of E. coli surrogates between 
the different treatments for beef cuts (Table 7). Reductions of E. coli surrogates ranged 
from 0.1-0.6 log10 CFU/50 cm2. 
4.2.3 In-Plant Trial #3 
Reductions of E. coli surrogate from application of Citrilow™ to beef cuts and 
beef trimmings were minimal (0.2 to 0.4 log10 CFU) (Table 8). Among beef cuts and 
trimmings treated with Citrilow, there were no differences (P > 0.05) among cut types 
for pre-treatment or post-treatment counts, or reductions. Beef cutlets treated with lactic 
acid had the lowest (P < 0.05) pre-treatment and post-treatment counts, but were the 
same (P > 0.05) as the Citrilow treated groups for reductions (Table 8). 
4.2.4 In-Plant Trial #4 
Pre-treatment counts of surrogate E. coli were higher (P < 0.05) on bottom 
rounds that on bottom round roasts, while post-treatment counts were not different (P > 
0.05) among all cuts (Table 9). Reduction of E. coli surrogates achieved by treatment 
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with Citrilow™ or lactic acid were minimal (0.2 to 0.4 log10 CFU/50 cm2), and did not 
differ across cuts and treatments (P > 0.05) (Table 9). 
4.2.5 Water Source Comparison 
Source of the water used to prepare the treatments did not affect (P > 0.05) 
reductions of E. coli. Lactic acid solutions prepared from both water sources resulted in 
0.8 log10 CFU/50 cm2 reduction. Citrilow™ solutions prepared from both water sources 
resulted in 0.7 log10 CFU/50 cm2 reduction (Table 10). These data suggest, in this 
specific case, the water source was not a factor in the efficacy of these antimicrobial 
solutions. 
4.2.6 In-Plant Trials Discussion 
The findings from these plant trials agree with previous research pertaining to the 
minimal efficacy of peroxyacetic acid solutions on chilled beef products (40, 74). Also, 
the results of the use of Beefxide® in these trials are contradictory to those observed by 
Laury et al. (76) and Hendricks et al. (57), who found that Beefxide® resulted in a 1.4 
log10 CFU/cm2 reduction of E. coli. Further investigation is needed to determine if other 
factors may be influencing the efficacy of these interventions. 
These results illustrate the challenges that exist pertaining to the efficacy of 
antimicrobial interventions on chilled beef subprimals. These data contradict the 
literature pertaining to the efficacy of lactic acid and Citrilow™ on chilled beef (37, 54, 
94, 95). Further investigation is needed to determine if other factors may be influencing 
the efficacy of the interventions. 
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4.3 Frozen Beef Surfaces 
4.3.1 Frozen Trimmings 
There was no difference (P > 0.05) between the 2 treatments for reduction of 
surrogate E. coli. Reductions of 0.5 and 0.7 log10 CFU/g were observed for 2.5% and 
5.0% warm lactic acid, respectively (Table 11).  
4.3.2 Fresh vs. Frozen 
There was a difference (P < 0.0001) for post-treatment counts of surrogate E. coli 
between the fresh and frozen treatment groups (Table 12). Reductions achieved on 
frozen cuts treated with 5.0% lactic acid were greater (P < 0.0001) than reductions from 
either of the fresh treatment groups (Table 12). There were no differences (P > 0.05) for 
reductions between lactic acid concentrations. These data suggest that freezing, in 
combination with a subsequent 5.0% lactic acid spray, may lead to more favorable 
reductions of E. coli than lactic acid applied to fresh beef.  
4.3.3 Frozen Beef Surfaces Discussion 
The literature suggests that freezing and thawing can result in the injury and 
subsequent death of a portion of microorganisms. However, the available literature also 
describes the inconsistent effects of freezing and the chance of pathogen survival 
throughout the freezing and thawing process (23, 35, 48, 79). If the membrane and other 
components of bacterial cells are damaged during the freezing process, they may be 
more susceptible to treatment with organic acids. Damage to the cell could allow for 
easier introduction of the undissociated acid molecules into the cytoplasm. Therefore, 
further investigation is needed pertaining to the effects of freezing, thawing, and 
  50 
antimicrobial spray on the survival of pathogens in meat products. Due to the lack of 
literature available pertaining to antimicrobial solutions applied to frozen meat, further 
research is needed to determine potential intervention strategies for frozen beef products.  
4.4 Moisture Enhanced Beef 
Based on the findings of the preliminary trial, internalization of the 
microorganisms was not affected based on the use of the vacuum packaging. Therefore, 
all cuts for marination trials #1 and #2 were vacuum packaged before vacuum tumbling.  
4.4.1 Marinated Trial #1 
There were no differences (P > 0.05) for reductions of surface E. coli between 
CPC and control, across all days of storage (Table 13). Also, there was no difference (P 
> 0.05) among treatment groups and days of storage for internal surviving E. coli 
surrogates (Table 14). 
4.4.2 Marinated Trial #2 
 Pre-treatment counts were the same (P > 0.05) across treatments, but post-
treatment surface E. coli were lower (P < 0.05) for the 0.10% CPC group (Table 15). 
Although there was not a statistical difference (P = 0.0696), the 0.10% CPC treatment 
reduced surface E. coli by 0.7 log10 CFU/50 cm2, while all other groups yielded a 0.5 
log10 CFU/50 cm2 reduction (Table 15). There was no (P > 0.05) difference between 
treatments for surviving surrogate E. coli recovered from internal core samples (Table 
16).  
 
 
  51 
4.4.3 Moisture Enhanced Beef Discussion 
The findings of trials #1 and #2 are similar to that of Adler et al. (2) and 
Byelashov et al. (15), who found that brines containing CPC were among the most 
effective at reducing pathogens in the meat. Previous research has used ground or 
comminuted beef products with antimicrobial ingredients added to the brine solutions. 
However, very few trials have investigated its use in an enhancement solution for whole-
muscle beef cuts. The levels at which CPC was utilized during these trials were chosen 
based on the minimum level that was predicted to be effective. The findings of these 
trials suggest that further investigation is needed to determine if using CPC as an 
antimicrobial ingredient is effective at reducing E. coli to an acceptable level in whole-
muscle, marinated beef products.  
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CHAPTER V 
CONCLUSIONS 
 
This research supports the use of pellets for transporting surrogates of STEC and 
Salmonella spp. to establishments for in-plant validation trials. Antimicrobial treatments 
for chilled beef were not as effective during in-plant trials as in previously published 
research. Further investigation may be warranted to determine the best combination of 
antimicrobial compounds, concentration, and solution temperature to reduce pathogens 
without negatively impacting the organoleptic quality of the end product.  
Results of these experiments were inconclusive pertaining to reduction of E. coli 
on frozen beef surfaces. With what we know about sub-lethal injury of cells due to 
freezing, it is possible that microorganisms are more susceptible to pH changes due to 
chemical interventions. Interaction between freezing and the application of lactic acid 
suggest that additional research should be conducted to determine the most effective 
methods for applying antimicrobial interventions to frozen beef for the reduction of 
pathogens.  
Data suggest that use of these antimicrobial compounds in a brine solution may 
be effective at reducing E. coli in moisture-enhanced, whole-muscle beef cuts. While 
there were tendencies for reduction of microorganisms due to treatments, it is unclear if 
these ingredients would be a reliable method of pathogen control in marinated beef. 
Further investigation is needed to determine the most effective use of these antimicrobial 
ingredients for whole-muscle marination. 
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The results of these trials demonstrate how surrogate microorganisms can be 
used to validate the application of antimicrobials on beef subprimals in-plant, frozen 
beef, and marinated beef cuts. Additional research in these areas are warranted to help 
provide more information to the beef industry. Beef processors can use this information 
to help design validation programs for their specific production processes.  
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Table 1. Mean concentration (log10 CFU/ml) of Escherichia coli pellet inoculum after 
different days of storage1. 
Days of Storage log10 CFU/ml 
2 8.8A 
3   8.6AB 
4 8.7A 
5 8.2B 
6 8.3B 
7 8.8A 
8 8.7A 
SEM 0.077 
P-value 0.0037 
Means within the row with differing superscripts (A-B) differ (P < 0.05). 
1 Pellets were stored under refrigeration (4°C).  
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Table 2. Least squares means of Escherichia coli (log10 CFU/cm2) on inoculated beef 
bottom rounds pre- and post-treatment1, stratified by inoculum preparation method. 
Means within rows with the same superscripts (A) are not different (P > 0.05). 
1 Treatment, lactic acid was prepared (88% L-lactic acid, Purac® FCC 88, Corbion, 
Lenexa, KS) to a concentration of 3.5% ± 0.1% (verified by titration) applied at 25ºC. 
2 Reduction = (log10 CFU/50 cm2 before treatment) – (log10 CFU/50 cm2 after treatment).  
 Inoculum Preparation Method   
 Cocktail Pellet SEM P-value 
Pre-treatment 5.9A 6.3A  0.206 0.2205 
Post-treatment 5.2A 5.2A  0.029 0.9857 
Reduction2 0.7A 1.1A  0.199 0.2077 
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Table 3. Least squares means of pre- and post-treatment counts, and reductions of Rif 
resistant Escherichia coli (log10 CFU/50 cm2) on inoculated beef bottom rounds, 
stratified by treatment and inoculum type. 
   Inoculum Type / Treatments   
        Cocktail          Pellet    
 Lactic acid1 Citrilow2 Lactic acid1 Citrilow2 SEM P-value 
Pre-treat 6.6A 6.5A 6.1B 6.0B 0.105 0.0152 
Post-treat 5.9A 5.7A 5.7A 5.5A 0.097 0.0776 
Reduction3 0.7A 0.8A 0.4A 0.5A 0.149 0.3512 
Means within rows with differing superscripts (A-B) differ (P < 0.05). 
1 Lactic acid was prepared (88% L-lactic acid, Purac® FCC 88, Corbion, Lenexa, KS) to 
a concentration of 3.5% ± 0.1% (verified by titration) applied at 25ºC. 
2 Citrilow™ was prepared (Safe Food Corp., North Little Rock, AR) to a pH of 1.05 ± 
0.01 (verified by standardized pH instrument) applied at 25°C. 
3 Reduction = (log10 CFU/50 cm2 before treatment) – (log10 CFU/50 cm2 after treatment).  
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Table 4. Least squares means of pre- and post-treatment counts, and reductions of Rif 
resistant Escherichia coli (log10 CFU/50 cm2) on inoculated beef bottom rounds, 
stratified by treatment and inoculum type. 
   Inoculum Type / Treatments   
  Cocktail Pellet  
 Lactic acid1 Citrilow2 Lactic acid1 Citrilow2 SEM P-value 
Pre-treat 6.4A 6.3A 6.0B 6.2B 0.068 0.0087 
Post-treat 5.5A 5.0A 5.1A 5.2A 0.151 0.1110 
Reduction3 0.9A 1.3A 0.8A 1.0A 0.127 0.0950 
Means within rows with differing superscripts (A-B) differ (P < 0.05). 
1 Lactic acid was prepared (88% L-lactic acid, Purac® FCC 88, Corbion, Lenexa, KS) to 
a concentration of 3.5% ± 0.1% (verified by titration) applied at 25ºC. 
2 Citrilow™ was prepared (Safe Food Corp., North Little Rock, AR) to a pH of 1.05 ± 
0.01 (verified by standardized pH instrument) applied at 25°C. 
3 Reduction = (log10 CFU/50 cm2 before treatment) – (log10 CFU/50 cm2 after treatment).  
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Table 5. Least squares means of the interaction of treatment x inoculation time on 
reductions1 of Rif resistant Escherichia coli (log10 CFU/50 cm2) on inoculated beef 
briskets. 
   Inoculum Time4   
Treatment  Pre-chill Post-chill SEM P-value 
25ºC Lactic acid2 1.4B 1.3B   
55ºC Lactic acid2 1.6B 1.3B   
25ºC Citrilow3   2.7AB   2.3AB   
55ºC Citrilow3 3.4A   2.1AB 0.329 0.0030 
Means with differing superscripts (A-B) differ (P < 0.05) for treatment x inoculation 
time interaction. 
1 Reduction = (log10 CFU/50 cm2 before treatment) – (log10 CFU/50 cm2 after treatment). 
2 Lactic acid was prepared (88% L-lactic acid, Purac® FCC 88, Corbion, Lenexa, KS) to 
a concentration of 3.5% ± 0.1% (verified by titration) applied to chilled beef briskets at 
25ºC and 55ºC. 
3 Citrilow™ was prepared (Safe Food Corp., North Little Rock, AR) to a pH of 1.05 ± 
0.01 (verified by standardized pH instrument) applied to chilled beef briskets at 25°C 
and 55ºC. 
4 Twelve briskets were inoculated pre-chilling (approx. 28°C) and 12 briskets were 
inoculated post-chilling (approx. 4°C).  
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Table 6. Least squares means of the interaction of treatment x cut type on reductions1 of 
Rif resistant Escherichia coli (log10 CFU/50 cm2) on inoculated beef cuts. 
   Treatment   
Cut Type  Inspexx 1502 Inspexx 2003 SEM P-value 
Knuckle 0.2B   0.3AB   
Short loin   0.3AB   0.3AB   
Sirloin 0.8A 0.8A   
Striploin   0.7AB   0.8AB 0.102 0.0003 
Means with differing superscripts (A-B) differ (P < 0.05) for treatment x cut type 
interaction. 
1 Reduction = (log10 CFU/50 cm2 before treatment) – (log10 CFU/50 cm2 after treatment). 
2 Inspexx™ 150 (Ecolab, St. Paul, MN) prepared to a concentration of 150 parts per 
million (verified by titration) applied at 13ºC. 
3 Inspexx™ 200 (Ecolab, St. Paul, MN) prepared to a concentration of 190 parts per 
million (verified by titration) applied at 13ºC.  
  73 
Table 7. Least squares means of the interaction of treatment x cut type on reductions1 of 
Rif resistant Escherichia coli (log10 CFU/50 cm2) on inoculated beef cuts. 
Means with the same superscripts (A) are not different (P > 0.05). 
1 Reduction = (log10 CFU/50 cm2 before treatment) – (log10 CFU/50 cm2 after treatment). 
2 Beefxide® (Birko Corporation, Henderson, CO) applied at 2.0% ± 0.1% (verified by 
titration) at 41ºC. 
3 Inspexx™ 150 (Ecolab, St. Paul, MN) prepared to a concentration of 150 parts per 
million (verified by titration) applied at 19ºC. 
4 Inspexx™ 200 (Ecolab, St. Paul, MN) prepared to a concentration of 190 parts per 
million (verified by titration) applied at 23ºC.  
  Treatment   
Cut Type Beefxide2 Inspexx 1503 Inspexx 2004 SEM P-value 
Knuckle 0.1A 0.3A 0.3A   
Striploin 0.4A 0.6A 0.2A 0.133 0.1421 
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Table 8. Least squares mean pre- and post-treatment counts, and reductions of 
Escherichia coli (log10 CFU1,2) on inoculated beef cuts and beef trimmings. 
Cut Type Treatment Pre-treatment Post-treatment Reduction5 
Bottom Round1 Citrilow3   6.0AB   5.7AB 0.3A 
Chuck Roll1 Citrilow3   6.0AB   5.9AB 0.2A 
Inside Round1 Citrilow3   6.2AB   5.8AB 0.4A 
Beef Trim2 Citrilow3 6.7A 6.5A 0.2A 
Beef Cutlets2 Lactic Acid4 5.2B 5.2B 0.2A 
SEM  0.252 0.277 0.090 
P-value  0.0038 0.0312 0.3606 
Means within columns with differing superscripts (A-B) differ (P < 0.05). 
1 Surface excision samples; means reported as log10 CFU/50 cm2. 
2 Surface samples were collected to reach a target mass; means reported as log10 CFU/g. 
3 Citrilow™ was prepared (Safe Food Corp., North Little Rock, AR) to a pH of 1.05 ± 
0.01 (verified by standardized pH instrument) applied at 25°C. 
4 Lactic acid was prepared (88% L-lactic acid, Purac® FCC 88, Corbion, Lenexa, KS) to 
a concentration of 3.5% ± 0.1% (verified by titration) applied at 25ºC. 
5 Reduction = (log10 CFU pre-treatment) – (log10 CFU post-treatment).  
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Table 9. Least squares mean reductions of Escherichia coli (log10 CFU/50 cm2) on 
inoculated beef bottom rounds, chuck rolls, and bottom round roasts. 
Cut Type Treatment Pre-treatment Post-treatment Reduction3 
Bottom Round Citrilow1 5.7A 5.3A 0.4A 
Chuck Roll Citrilow1   5.6AB 5.3A 0.3A 
Btm. Round Rst. Lactic Acid2 5.4B 5.2A 0.2A 
SEM  0.057 0.063 0.065 
P-value  0.0021 0.1670 0.5355 
Means within columns with differing superscripts (A-B) differ (P < 0.05). 
1 Citrilow™ was prepared (Safe Food Corp., North Little Rock, AR) to a pH of 1.05 ± 
0.01 (verified by standardized pH instrument) applied at 25°C. 
2 Lactic acid was prepared (88% L-lactic acid, Purac® FCC 88, Corbion, Lenexa, KS) to 
a concentration of 3.5% ± 0.1% (verified by titration) applied at 25ºC. 
3 Reduction = (log10 CFU/50 cm2 before treatment) – (log10 CFU/50 cm2 after treatment).  
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Table 10. Least squares mean reductions of Escherichia coli (log10 CFU/50 cm2) on 
inoculated beef cuts, stratified by water source and treatment1,2. 
Water Source Treatment Reduction3 
TAMU Citrilow2 0.7A 
PA Citrilow2 0.7A 
TAMU Lactic Acid3 0.8A 
PA Lactic Acid3 0.8A 
SEM  0.098 
P-value  0.6178 
Means with the same superscripts (A) are not different (P > 0.05). 
1 Citrilow™ was prepared (Safe Food Corp., North Little Rock, AR) to a pH of 1.05 ± 
0.01 (verified by standardized pH instrument) applied at 25°C. 
2 Lactic acid was prepared (88% L-lactic acid, Purac® FCC 88, Corbion, Lenexa, KS) to 
a concentration of 3.5% ± 0.1% (verified by titration) applied at 25ºC. 
3 Reduction = (log10 CFU/50 cm2 before treatment) – (log10 CFU/50 cm2 after treatment).  
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Table 11. Least squares means of Escherichia coli (log10 CFU/g) on inoculated frozen 
beef trimmings post-inoculation and post-treatment, stratified by lactic acid1 
concentration. 
Means within the same row with same superscripts (A) are not different (P > 0.05). 
1 Lactic acid was prepared (88% L-lactic acid, Purac® FCC 88, Corbion, Lenexa, KS) to 
a concentration of 2.5% and 5.0% ± 0.1% (verified by titration) applied at 55ºC. 
2 Reduction = (log10 CFU/g after inoculation) – (log10 CFU/g after treatment).  
 Lactic Acid Concentration1   
 2.5 % 5.0 % SEM P-value 
Post-inoculation 6.6A 6.6A 0.054 0.3996 
Post-treatment 6.1A 5.9A 0.059 0.1521 
Reduction2 0.5A 0.7A 0.065 0.0505 
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Table 12. Least squares means of Escherichia coli (log10 CFU/50 cm2) on inoculated 
beef cuts pre- and post-treatment, and reductions, stratified by lactic acid1 concentration 
and freezing3 treatment. 
   Freezing Treatments / Lactic Acid Concentrations   
  Fresh2        Frozen3   
 2.5%1 5.0%1 2.5%1 5.0%1 SEM P-value 
Pre-treat 4.8A 4.8A 4.8A 4.7A 0.061 0.8867 
Post-treat 4.0A 3.8A 3.4B 3.2B 0.090 < .0001 
Reduction4 0.8C  1.0BC   1.4AB 1.5A 0.113 < .0001 
Means within rows with differing superscripts (A-C) differ (P < 0.05). 
1 Lactic acid was prepared (88% L-lactic acid, Purac® FCC 88, Corbion, Lenexa, KS) to 
a concentration of 2.5%± 0.1% and 5.0% ± 0.1% (verified by titration) applied at 25ºC. 
2 Cuts assigned to the Fresh groups were treated with either 2.5% or 5.0% lactic acid. 
3 Cuts assigned to the Frozen groups were stored in the freezer (-20°C) for approximately 
24 h before treatment with either 2.5% or 5.0% lactic acid. 
4 Reduction = (log10 CFU/50 cm2 after inoculation) – (log10 CFU/50 cm2 after treatment).  
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Table 13. Least squares means of the interaction of treatment x days of storage on 
reductions1 of surface Escherichia coli (log10 CFU/50 cm2) of inoculated marinated beef 
tri-tips on day 0, 2, and 4 of refrigerated (4°C) storage. 
Means with the same superscripts (A) are not different (P > 0.05). 
All cuts were vacuum tumbled for 30-min after treatments were applied, then stored 
under refrigeration (4°C) for 0, 2, or 4 days before post-treatment samples were 
collected. 
1 Reductions = (log10 CFU/50 cm2 before treatment) – (log10 CFU/50 cm2 after 
treatment). 
2 CON, Control, marinated with no antimicrobial added. 
3 CPC, cetylpyridinium chloride (0.02%, added as Cecure® 40.0% stock solution, Safe 
Foods Corp., North Little Rock, AR).  
  Days of Storage   
Treatment 0 2 4 SEM P-value 
CON2 0.5A 0.6A 0.5A   
CPC3 0.5A 0.6A 0.5A 0.075 0.6968 
  80 
Table 14. Least squares means of the interaction of treatment x days of storage on 
surviving internalized Escherichia coli (log10 CFU/g) of inoculated marinated beef tri-
tips on day 0, 2, and 4 of refrigerated (4°C) storage. 
Means with the same superscripts (A) are not different (P > 0.05). 
All cuts were vacuum tumbled for 30-min after treatments were applied, then stored 
under refrigeration (4°C) for 0, 2, or 4 days before internal samples were collected. 
1 CON, Control, marinated with no antimicrobial added. 
2 CPC, cetylpyridinium chloride (0.02%, added as Cecure® 40.0% stock solution, Safe 
Foods Corp., North Little Rock, AR).  
  Days of Storage   
Treatment 0 2 4 SEM P-value 
CON1 3.0A 3.1A 2.4A   
CPC2 2.3A 2.5A 2.4A 0.278 0.1775 
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Table 15. Least squares means of Escherichia coli (log10 CFU/50 cm2) on inoculated 
and marinated beef tri-tips pre- and post-treatment, and reductions; stratified by 
treatment. 
 Treatments   
 CON1 Avgard2 0.05% CPC3 0.10% CPC4 SEM P-value 
Pre-treat 4.9A 4.8A 4.8A 4.7A 0.057 0.2486 
Post-treat 4.4A 4.3A 4.3A 4.0B 0.057 0.0007 
Reduction5 0.5A 0.5A 0.5A 0.7A 0.064 0.0696 
Means within rows with differing superscripts (A-B) differ (P < 0.05). 
All cuts were vacuum tumbled for 30-min after treatments were applied, then stored 
under refrigeration (4°C) for 4 days before post-treatment samples were collected. 
1 CON, Control, marinated with no antimicrobial added. 
2 AvGard, sodium metasilicate (0.2%, added as AvGard® XP, Danisco USA, Inc., New 
Century, KS). 
3 0.05% CPC, cetylpyridinium chloride (0.05%, added as Cecure® 40.0% stock solution, 
Safe Foods Corp., North Little Rock, AR). 
4 0.10% CPC, cetylpyridinium chloride (0.10%, added as Cecure® 40.0% stock solution, 
Safe Foods Corp., North Little Rock, AR). 
5 Reduction = (log10 CFU/50 cm2 before treatment) – (log10 CFU/50 cm2 after treatment).  
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Table 16. Least squares means of internal surviving Escherichia coli (log10 CFU/g) in 
inoculated and marinated beef tri-tips; stratified by treatment. 
 Treatments   
 CON1 Avgard2 0.05% CPC3 0.10% CPC4 SEM P-value 
Internal Survivors 2.4A 2.4A 2.7A 2.1A 0.176 0.2226 
Means with the same superscripts (A) are not different (P > 0.05). 
All cuts were vacuum tumbled for 30-min after treatments were applied, then stored 
under refrigeration (4°C) for 4 days before internal samples were collected. 
1 CON, Control, marinated with no antimicrobial added. 
2 AvGard, sodium metasilicate (0.2%, added as AvGard® XP, Danisco USA, Inc., New 
Century, KS). 
3 0.05% CPC, cetylpyridinium chloride (0.05%, added as Cecure® 40.0% stock solution, 
Safe Foods Corp., North Little Rock, AR). 
4 0.10% CPC, cetylpyridinium chloride (0.10%, added as Cecure® 40.0% stock solution, 
Safe Foods Corp., North Little Rock, AR). 
